Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study.
Josting A, Sieniawski M, Glossmann JP, Staak O, Nogova L, Peters N, Mapara M, Dörken B, Ko Y, Metzner B, Kisro J, Diehl V, Engert A. Josting A, et al. Among authors: mapara m. Ann Oncol. 2005 Aug;16(8):1359-65. doi: 10.1093/annonc/mdi248. Epub 2005 Jun 6. Ann Oncol. 2005. PMID: 15939712 Free article. Clinical Trial.
Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease.
Josting A, Rudolph C, Reiser M, Mapara M, Sieber M, Kirchner HH, Dörken B, Hossfeld DK, Diehl V, Engert A; Participating Centers. Josting A, et al. Among authors: mapara m. Ann Oncol. 2002 Oct;13(10):1628-35. doi: 10.1093/annonc/mdf221. Ann Oncol. 2002. PMID: 12377653 Free article. Clinical Trial.
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).
Josting A, Rudolph C, Mapara M, Glossmann JP, Sieniawski M, Sieber M, Kirchner HH, Dörken B, Hossfeld DK, Kisro J, Metzner B, Berdel WE, Diehl V, Engert A. Josting A, et al. Among authors: mapara m. Ann Oncol. 2005 Jan;16(1):116-23. doi: 10.1093/annonc/mdi003. Ann Oncol. 2005. PMID: 15598948 Free article. Clinical Trial.
Nonmyeloablative stem cell transplantation in metastatic renal cell carcinoma: delayed graft-versus-tumor effect is associated with chimerism conversion but transplantation has high toxicity.
Massenkeil G, Roigas J, Nagy M, Wille A, Stroszczynski C, Mapara MY, Loening S, Dörken B, Arnold R. Massenkeil G, et al. Among authors: mapara my. Bone Marrow Transplant. 2004 Aug;34(4):309-16. doi: 10.1038/sj.bmt.1704587. Bone Marrow Transplant. 2004. PMID: 15220955
124 results